Stress urinary incontinence
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Women older than 18 years of age and younger than 70 years of age (2) Mild to moderate stress urinary incontinence as diagnosed by a physician (Using the Ingelman-Sundberg indexing method) (3)The patient agrees not to use any treatment (drug or other form) known to affect lower urinary tract function throughout treatment and follow-up; (4) Voluntary participation in this study and signed informed consent form
Exclusion criteria
Exclusion criteria: (1) within 3 months after pelvic surgery; (2) Severe SUI (Ingelman-Sundberg scale method) (3) People who cannot use smart phones and have disabilities in listening, speaking, reading and writing; (4) Patients with a history of urinary incontinence surgery or pelvic floor surgery within 6 months before the trial; (5) Diagnosed with vesicoureteral reflux, pelvic organ or vaginal prolapse stage II or above; The presence of malformations that cause urinary incontinence; (6) Patients with acute reproductive and urinary system infection within one week and not cured; (7) Used midodine hydrochloride, tolterodine, vaginal local estrogen and other drugs for urinary incontinence within 1 week before the test; (8) Uncontrolled diabetes, multiple sclerosis, stroke, Parkinson's disease, spinal cord injury, cauda equina nerve injury, multisystem atrophy, mental disorders (depression, anxiety, etc.) and other systemic diseases that may affect the function of the lower urinary tract; (9) Participated in other drug clinical trials or device clinical trials and used test drugs or devices within 3 months before the test; (10) Diagnosed patients with cervical cancer and precancerous lesions; (11) Previous history of drug use and drug abuse (12) Those who are considered unsuitable for the study by the researcher;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of urine leakage;International Consultationon Incontinenee Questionnaire-Short Form;Broome pelvic muscle self-efficacy scale, BPMSES; | — |
Secondary
| Measure | Time frame |
|---|---|
| stress urinary incontinence knowledge questionnaire;pelvic floor muscle training compliance questionnaire;urinary incontinence impact questionnaire short form ; | — |
Countries
China
Contacts
The First Hospital of Shanxi Medical University